川潤股份(002272.SZ):公司的液冷產品已在風電領域有多年成熟應用
格隆匯2月5日丨川潤股份(002272.SZ)近日在接待機構投資者調研時表示,公司的液冷產品已經在風電領域有多年成熟應用,並形成了公司深刻的細分場景應用技術和經驗。公司液冷產品具有低能耗、高散熱、低噪聲、低TCO等優勢,可在儲能、數據中心、雲計算、算力設備、通信網絡、電力電網、電源轉換等領域為客户提供液冷產品和温控節能解決方案。
在儲能液冷領域,公司已經通過行業客户應用,並實現銷售收入;在IDC、服務器液冷領域,公司加強產品開發與驗證,已實現小額銷售收入,目前正在積極拓展國內和歐美市場客户資源,有望加速實現業務目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.